Simultaneous measurement of ATP-sensitive K current and fluorescent imaging.

同时测量 ATP 敏感 K 电流和荧光成像。

基本信息

项目摘要

The ATP-sensitive K^+ (K_<ATP>) channel is a heteromultimer composed of four inwardly rectifying K^+ channels (Kir6.2) and four sulfonylurea receptors (SUR). Intracellular ATP binds to Kir6.2 and inhibits K_<ATP> channel. Nucleotide diphosphates (NDPs) binds to SUR, thereby increases the open probability of, and decreases the ATP-sensitivity of K_<ATP> channel. SUR is a member of ATP-binding cassette (ABC) superfamily. possessing two nucleotide binding folds (NBF). Prokaryotic members of ABC superfamily such as HisP and RbsA are termed "half-size ABC proteins", and possess only one NBF, and form a functional dimer in the cell membrane. We splited SUR2A into two "half-size molecules" before and after NDB1, and found that they could reassemble with Kir6.2 to form a functional K_<ATP> channel. C-terminal half SUR (C640) conferred glibenclamide sensitivity to Kir delta C36, whereas C640 did not increase open probability of Kir6.2 delta C36. We also made fusion proteins of yellow fluorescent protein (YFP) or cyan fluorescent protein (CFP) with split SURs and Kir6.2, and tried to identify fluorescent resonance energy transfer (FRET) between CYP and YFP. However, pharmacological stimuli with K channel openers and glibenclamide failed to induce the changes of FRET ratio. We also found that fluorescent labeled ATP could successfully inhibited the fusion protein of GFP and Kir6.2delta C36. However, it was difficult to identify FRET between fluorescent labeled ATP and GFP.
ATP敏感性K^+(K_<ATP>)通道是由四个内向整流K^+通道(Kir6.2)和四个磺酰脲受体(SUR)组成的异源多聚体。细胞内ATP与Kir6.2结合,抑制K_<ATP>通道。核苷酸二磷酸(NDP)与SUR结合,增加了K通道的开放概率,降低了K通道的ATP敏感性<ATP>。SUR是ATP结合盒(ABC)超家族的成员。具有两个核苷酸结合折叠(NBF)。ABC超家族的前体成员如HisP和RbsA被称为“半大小ABC蛋白”,它们只有一个NBF,在细胞膜上形成功能性二聚体。我们将SUR 2A在NDB 1前后分裂成两个“半分子”,发现它们可以与Kir6.2重组形成功能性K_<ATP>通道。C-末端半SUR(C640)赋予格列本脲对Kir δ C36的敏感性,而C640并未增加Kir6.2 δ C36的开放概率。我们还制备了黄色荧光蛋白(YFP)或青色荧光蛋白(CFP)与分裂的SURs和Kir6.2的融合蛋白,并试图鉴定荧光素酶和YFP之间的荧光共振能量转移(FRET)。然而,药物刺激与K通道开放剂和格列本脲未能诱导FRET比率的变化。荧光标记的ATP能有效抑制GFP与Kir6.2 delta C36融合蛋白的表达。然而,荧光标记的ATP和GFP之间的FRET很难识别。

项目成果

期刊论文数量(34)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ninomiya, T., Takano, M., Tsuji, K., Haruna, T., Kono, Y., Yoshida, H., Kubota, T.: "Verapamil, a Ca^<2+> entry blocker, targets pore-forming subunit of cardiac type K_<ATP> channel(Kir6.2)"Journal of Cardiovascular Pharmacology. 42. 161-168 (2003)
Ninomiya, T.、Takano, M.、Tsuji, K.、Haruna, T.、Kono, Y.、Yoshida, H.、Kubota, T.:“维拉帕米,一种 Ca^<2> 进入阻滞剂,针对毛孔
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Stretch-induced I_<ks> enhancement requires KvLQT1, but not KCNE1 subunit, as a mechanosensitive sensor.
拉伸引起的 I_<ks> 增强需要 KvLQT1,但不需要 KCNE1 亚基作为机械敏感传感器。
Cho, HS., Takano, M., Noma, A.: "Electrophysiogical properties of spontaneously beating pacemaker cells isolated from mouse sino-atrial node"Journal of Physiology. 550. 169-180 (2003)
Cho, HS.、Takano, M.、Noma, A.:“从小鼠窦房结中分离出的自发跳动起搏细胞的电生理特性”生理学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Additional gene variants reduce effectiveness of b-blockers in the LQT1 form of long QT syndrome.
其他基因变异会降低 b 受体阻滞剂在 LQT1 形式的长 QT 综合征中的有效性。
Verapamil, a Ca^<2+> entry blocker, targets pore-forming subunit of cardiac type K_<ATP> channel (Kir6. 2).
Verapamil 是一种 Ca^2 进入阻滞剂,靶向心脏型 K_<ATP> 通道 (Kir6.2) 的成孔亚基。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TAKANO Makoto其他文献

光敏色素影响赤霉素调控的水稻幼苗光形态建成特征
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
    刘婧;柳艳梅;TAKANO Makoto;王宝山;谢先芝
  • 通讯作者:
    谢先芝

TAKANO Makoto的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TAKANO Makoto', 18)}}的其他基金

Novel physiological role of HCN4 channel in the sinoatrial node revealed with TET-off genetic switch system
TET-off 基因开关系统揭示了窦房结中 HCN4 通道的新生理作用
  • 批准号:
    16H05124
  • 财政年份:
    2016
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Identification of HCN4-expressing neurons using HCN4-luciferase knock-in mouse
使用 HCN4 荧光素酶敲入小鼠鉴定 HCN4 表达神经元
  • 批准号:
    26670292
  • 财政年份:
    2014
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
HCN4-luciferase knock-in mouse is a new tool for pacemaker cell reprogramming
HCN4-荧光素酶敲入小鼠是起搏细胞重编程的新工具
  • 批准号:
    24300145
  • 财政年份:
    2012
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Transcriptional mechanisms of sino-atrial node specific channel HCN4 in the heart.
心脏窦房结特异性通道HCN4的转录机制。
  • 批准号:
    20300141
  • 财政年份:
    2008
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Remodelling of Kir6. x after cardiac Tschemia and its functional consequence
Kir6的改造。
  • 批准号:
    10670041
  • 财政年份:
    1998
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

The mechanism of cardio-protection from a sulfonylurea receptor isoform 2 splice variant (SUR2A-55) and its role in regulating ROMK activity, the putative mitochondrial ATP sensitive potassium channel
磺酰脲受体亚型 2 剪接变体 (SUR2A-55) 的心脏保护机制及其在调节 ROMK 活性(假定的线粒体 ATP 敏感钾通道)中的作用
  • 批准号:
    10514603
  • 财政年份:
    2020
  • 资助金额:
    $ 9.09万
  • 项目类别:
The mechanism of cardio-protection from a sulfonylurea receptor isoform 2 splice variant (SUR2A-55) and its role in regulating ROMK activity, the putative mitochondrial ATP sensitive potassium channel
磺酰脲受体亚型 2 剪接变体 (SUR2A-55) 的心脏保护机制及其在调节 ROMK 活性(假定的线粒体 ATP 敏感钾通道)中的作用
  • 批准号:
    10293567
  • 财政年份:
    2020
  • 资助金额:
    $ 9.09万
  • 项目类别:
The mechanism of cardio-protection from a sulfonylurea receptor isoform 2 splice variant (SUR2A-55) and its role in regulating ROMK activity, the putative mitochondrial ATP sensitive potassium channel
磺酰脲受体亚型 2 剪接变体 (SUR2A-55) 的心脏保护机制及其在调节 ROMK 活性(假定的线粒体 ATP 敏感钾通道)中的作用
  • 批准号:
    10013619
  • 财政年份:
    2020
  • 资助金额:
    $ 9.09万
  • 项目类别:
Studies of the molecular mechanisms by which mutations in the SUR2A NBDs cause cardiovascular diseases
SUR2A NBDs突变导致心血管疾病的分子机制研究
  • 批准号:
    241284
  • 财政年份:
    2011
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Salary Programs
Studies of the molecular mechanisms by which mutations in the SUR2A NBDs cause cardiovascular diseases
SUR2A NBDs突变导致心血管疾病的分子机制研究
  • 批准号:
    201150
  • 财政年份:
    2010
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Operating Grants
Biochemical and biophysical studies of SUR2A NBDs
SUR2A NBD 的生化和生物物理研究
  • 批准号:
    396974-2010
  • 财政年份:
    2010
  • 资助金额:
    $ 9.09万
  • 项目类别:
    University Undergraduate Student Research Awards
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了